reports
Autolus Therapeutics to Participate in Upcoming Investor Conferences
Autolus Therapeutics to Participate in Upcoming Investor Conferences LONDON, May 29, 2025 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces that the Company will participate in upcoming investor conferences. William Blair 45th Annual Growth Stock ConferenceManagement to host investor meetingsDate: June 3, 2025Location: Chicago, IL Jefferies Global Healthcare ConferenceFireside Chat PresentationDate and time: June 5, 2025; 3:10pm E...
- ING Helpdesk
- Guy Sips
- Hilde Van Boxstael
- Jacob Mekhael
- Thomas Vranken
- Wim Hoste
- Wim Lewi
- Guy Sips
EVS Broadcast Equipment Target Tweaked, Confidence Sustained
We updated our model after EVS highlighted 1Q25 was slightly below its own expectations, primarily due to the deferral of certain customer deliveries from March to April. EVS stressed that this timing-related impact does not alter their underlying business momentum. EVS indicated that customer demand remains robust across all regions. We welcome EVS remains cautiously optimistic about achieving its FY25 revenue objectives though, given the macro-economic tensions, the tariff discussions and the ...
- Wim Lewi
Retail Estates FY24/25 Results slightly below on lower investment volu...
RET reported its FY24/25 results (March end) below our estimates. EPRA EPS amounted to EUR 6.21 vs. our expectation of 6.47. NRI grew 2.4% to 142.2m vs. 145.7m expected. Despite many bankruptcies, occupancy remained relatively stable at 97.3% from 97.6% at 1H24/25. The difference with our expectations results from lower net investments of EUR 16.7m than expected (80.0m) as the market for large properties remained slow. The debt ratio improved from 44.52% to 42.52%. RET confirmed its FY24/25 divi...
- Jacob Mekhael
Autolus Receives positive CHMP opinion for Aucatzyl in r/r adult ALL i...
Friday during trading hours, Autolus announced the EMA's CHMP issued a positive opinion for Aucatzyl (CD19 CAR-T) in r/r adult ALL. The European Commission is expected to make a decision on marketing approval in the EU within approx. 2 months, and usually follows the CHMP opinion. Commercial launch in Europe is expected to be on a country by country basis, and the company has previously indicated that the initial focus in Europe will be on Germany and the UK. With initial US sales showing solid ...
Autolus Therapeutics Announces Positive CHMP Opinion for Obecabtagene ...
Autolus Therapeutics Announces Positive CHMP Opinion for Obecabtagene Autoleucel for Adult Patients (age 26 and older) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL) Positive CHMP opinion based on FELIX clinical trial of obecabtagene autoleucel (obe-cel) in adult patients with r/r B-ALL, demonstrating high and durable response rates and low toxicityOpinion follows FDA approval and MHRA conditional marketing authorisationEuropean Commission (EC) decision on conditional marketing authorization application (MAA) expected within approximately two months L...
- Guy Sips
- Hilde Van Boxstael
- Thomas Vranken
- Wim Hoste
- Wim Lewi
EVS Invites Its Shareholders to a Postponed Extraordinary General Meet...
EVS Invites Its Shareholders to a Postponed Extraordinary General Meeting on June 10, 2025 EVS INVITES ITS SHAREHOLDERS TO A POSTPONED EXTRAORDINARY GENERAL MEETING ON JUNE 10, 2025 As already communicated on May 20, 2025, due to the lack of attendance quorum, the Extraordinary General Meeting of EVS Broadcast Equipment SA convened on May 20, 2025 is postponed to June 10, 2025, at 12:00 pm, at its registered office in Liège, to deliberate on the agenda available on the website of the company (see link below). The Board of Directors will propose to this effect to the Shareholders to appr...
EVS INVITE SES ACTIONNAIRES À UNE ASSEMBLÉE GÉNÉRALE EXTRAORDINAIRE RE...
EVS INVITE SES ACTIONNAIRES À UNE ASSEMBLÉE GÉNÉRALE EXTRAORDINAIRE REPORTEE LE 10 JUIN 2025 EVS INVITE SES ACTIONNAIRES À UNE ASSEMBLÉE GÉNÉRALE EXTRAORDINAIRE REPORTEE LE 10 JUIN 2025 Comme déjà communiqué le 20 mai 2025, l’Assemblée Générale Extraordinaire de EVS Broadcast Equipment SA convoquée le 20 mai 2025 n’ayant pas réuni le quorum de présence requis est reportée au 10 juin 2025, à 12:00 heures, à son siège social à Liège pour se prononcer sur l’agenda tel que publié sur le site internet de la société (voir lien ci-dessous). Le Conseil d'Administration proposera à cet effet aux...
- Guy Sips
- Hilde Van Boxstael
- Kristof Samoy
- Livio Luyten
- Michiel Declercq
- Thibault Leneeuw
- Thomas Couvreur
- Wim Hoste
Benelux Local Champions 27 May 2025
This conference book is your guide to our annual Benelux Local Champions Conference set to take place on Tuesday, 27 May 2025 at our historic building at Grand Place in Brussels. This event offers the possibility to have one-on-one meetings and/or small group meetings with the following Benelux companies and their top management & IR. ACKERMANS & VAN HAAREN | AGEAS | AHOLD DELHAIZE | AKZONOBEL | ARCADIS | AZELIS | CORBION | GBL | KBC GROUP | LOTUS BAKERIES | MELEXIS | PROXIMUS | SOFINA | UMIC...
GBLB GROUPE BRUXELLES LAMBERT SA
AGS AGEAS SA/NV
KBC KBC GROUP N.V.
LOTB LOTUS BAKERIES NV
SOF SOFINA SA
ACKB ACKERMANS & VAN HAAREN NV
ARCAD ARCADIS NV
MELE MELEXIS NV
CSM CORBION NV
AD KONINKLIJKE AHOLD DELHAIZE N.V.
UMI UMICORE
AKZA AKZO NOBEL N.V.
AZE AZELIS GROUP NV
EVS Communicates the Results of the Ordinary General Meeting
EVS Communicates the Results of the Ordinary General Meeting EVS COMMUNICATES THE RESULTS OF THE ORDINARY GENERAL MEETING EVS Broadcast Equipment SA, leading provider of live video production systems, held its Ordinary General Meeting on May 20, 2025. In total 154 shareholders representing 3,726,794 shares, or 26.01% of the company shares, attended (by proxy and physically) the Ordinary General Meeting held physically at the company's registered office. All the resolutions have been approved, i.e.:- The remuneration report, the discharge of the Directors and the Auditor;- The 2024 a...
EVS COMMUNIQUE LES RESULTATS DE L’ASSEMBLEE GENERALE ORDINAIRE
EVS COMMUNIQUE LES RESULTATS DE L’ASSEMBLEE GENERALE ORDINAIRE EVS COMMUNIQUE LES RESULTATS DE L’ASSEMBLEE GENERALE ORDINAIRE EVS Broadcast Equipment SA, leader des systèmes de production vidéo en direct, a tenu ce mardi 20 mai 2025 son Assemblée Générale Ordinaire. Au total, 154 actionnaires représentant 3.726.794 titres, soit 26,01% du capital de la société, ont pris part par procuration et physiquement à cette Assemblée qui s’est déroulée physiquement au siège social de la société. Toutes les résolutions ont été approuvées, à savoir :- Le rapport de rémunération, la décharge aux A...
- Guy Sips
- Jacob Mekhael
- Kristof Samoy
- Thomas Couvreur
- Thomas Vranken
- Wim Hoste
- Thomas Vranken
Biotalys FIRST LOOK: Unlocking post-harvest setting with AgroFresh par...
Biotalys has entered a collaboration with US-based AgroFresh Solutions to develop and commercialize its biocontrols for post-harvest use, targeting a $ ~300m global market. AgroFresh is a global leader in the post-harvest niche and featured $ 162m revenues at the time of its takeover by private equity Paine Schwartz in 2023, having grown significantly from ~300 to ~700 employees since then. We see the collaboration as highly complementary to Biotalys' pre-harvest efforts as it unlocks access to ...
- ING Helpdesk
Benelux Morning Notes
EVS: Weak start to the year, sales guidance maintained excluding FX, EBIT guidance low Just Eat Takeaway.com: Prosus offer launched KBC: CFO meeting – navigating above targets, strong loan growth & NII path NEPI Rockcastle: Robust Q1 results, strong top line Xior Student Housing: Dutch rent freeze not applicable to Xior
- Guy Sips
- Hilde Van Boxstael
- Lynn Hautekeete
- Michiel Declercq
- Wim Lewi
- Guy Sips
EVS Broadcast Equipment 1Q slightly below expectations but EVS remains...
EVS highlighted 1Q25 was slightly below its own expectations, primarily due to the deferral of certain customer deliveries from March to April. EVS stressed that this timing-related impact does not alter their underlying business momentum. EVS indicated that customer demand remains robust across all regions, providing continued confidence in its FY25 guidance. about achieving its FY25 revenue objectives though, given the macro-economic tensions, the tariff discussions and the weakening dollar. A...
EVS Q1 2025 business update
EVS Q1 2025 business update EVS Q1 2025 business update Despite increasing economic uncertainty, EVS remains cautiously optimistic for 2025 Liège, Belgium | May 16, 2025 We begin the year 2025 reporting a first quarter slightly below our expectations, primarily due to the deferral of certain customer deliveries from March to April. This timing-related impact does not alter the underlying business momentum. Customer demand remains robust across all regions, providing continued confidence in our full-year guidance. We remain cautiously optimistic about achieving our 2025 revenue object...
Point sur résultats de l’activité du 1er trimestre 2025 d’EVS
Point sur résultats de l’activité du 1er trimestre 2025 d’EVS Point sur résultats de l’activité du 1er trimestre 2025 d’EVS Malgré l'incertitude économique croissante, EVS reste prudemment optimiste pour 2025 Liège, Belgique | Le 16 mai 2025 Nous commençons l'année 2025 avec un premier trimestre légèrement inférieur à nos attentes, principalement en raison du report de certaines livraisons aux clients de mars à avril. Cet impact lié au calendrier ne modifie pas la dynamique commerciale sous-jacente. La demande des clients reste robuste dans toutes les régions, ce qui renforce la conf...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.